Well, yeah, but I'm interested in the actual financials.
Well, yeah, but I'm interested in the actual financials. So I want to see the Q2 -10Q financials because that is what I know. The subsequent events statements are not as interesting to me as a long because I don't really care where the stock ends at the end of today. I'm interested in what it looks like on March 4, 2017.
Note 8's can still be debated, financial statements, not nearly as much room for debate.
Besides, I got to post about something I know. After my yesterday head explosion in felt a need to feel smart again.
Q1 notes are fine but there will not be any revenues/expenses from operations, though there might be work in process and unfinished goods showing (which will also be good to see.)
Q2 financials, however, will settle all current questions.
3
Trans-Pacific Aerospace (TPAC) Stock Research Links
I'm only responsible for what I say, not for what you understand.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Standing on the Precipice of Index Innovation There’s a seismic shift rumbling through Vermiculus as they roll out their latest brainchild, the VeriIndex. This isn’t just your typical release; it’s the kind of shakeup that slaps you awake like a splash of cold water. Ever since they burst onto the scene in 2020, Vermiculus has been stirring the pot of exchange...
Continue Reading
Who would've thought Halloween would toss a spin on fine dining? What's usually known for candy corn and spooky costumes has teamed up with European flavors for a night unlike any other. And we're talking more than just trick-or-treating here, folks. A New Kind of Halloween Spread This year, The Charming Taste of Europe has thrown itself into the Halloween festivities,...
Continue Reading
A Tragic Verdict Worth Millions In the heart-wrenching case of former OB/GYN Arthur Park, the verdict has fallen like a ton of bricks. A jury in Bakersfield, California, has determined that Park's negligent care led to fatalities, resulting in a mammoth $9.25 million payout to two grief-stricken families. It's a bitter pill to swallow for Arthur Park, but an expected...
Continue Reading
A Change in Greenland Energy's Lineup Well, folks, the wheel keeps turning at Greenland Energy Company (NASDAQ:GLND). Roderick McIllree has decided to step off the Board of Directors' carousel, effective immediately. And nope, there wasn't a classic showdown or any disagreement on the table. This exit is as drama-free as they come—just him stepping aside, leaving the...
Continue Reading
Everyone’s eyeballs are glued to the burning issue of lithium-ion battery fires, and for good reason. They’re ticking time bombs, especially in those fancy new electric vehicles and gadgets. But stepping into the ring with solutions like they’re fighting windmills, Packaging and Crating Technologies (PACT®) took the spotlight at the recent Battery Show in Detroit,...
Continue Reading
Unlocking the Secrets of First Dental Visits When should little ones start showing up in that dental chair? You might be thinking, "I'll wait until they actually have a full set of chompers," but that's a rookie move, folks. A piece coming out of HelloNation suggests parents hustle those kiddos into the dentist's office by their first birthday or six months after the...
Continue Reading
A Celebration of a Visionary in Chinese Art In the typically bustling city of Hangzhou, a quiet reverence fell at the China Academy of Art (CAA) on October 17–18, 2026. There, they marked the centenary of one of the titans of art history, James Francis Cahill. He was the kind of person who could walk into a room and change how you looked at the walls. His legacy...
Continue Reading
Unicycive's Rough Ride: Not Just a Bump Picture this: Your stock takes a nosedive over 39% in a day, just after a critical drug application gets slammed by the FDA—for the second time. That’s the story with Unicycive Therapeutics, Inc., ticker NASDAQ: UNC, a company that's been handing out one nail-biting moment after another to its investors. It's not just a minor...
Continue Reading
Workday's Strategic Financial Maneuver When a company like Workday starts shaking the trees for $2.5 billion through a senior notes offering, you better believe traders like me are perking up and paying attention. We're talking a registered public offering, no less, which isn't peanuts. With such a substantial move, it's clear Workday (NASDAQ: WDAY) is setting its sights...
Continue Reading
Legacies, Stardom, and Stirring Conversations The Roundtable, eh? A gathering of some big names from different worlds pulling back the curtain on expectations and legacy. You've got WWE powerhouses Cody Rhodes and Charlotte Flair huddled together with actor O'Shea Jackson Jr. to cook up some thought-provoking dialogue. It's a gig set up by Jacob Heyman under the banner of...
Continue Reading
Top 5 Most Recently Viewed Articles
Explore the New 2025 Toyota Corolla For those in search of a stylish, fuel-efficient, and tech-savvy sedan, the 2025 Toyota Corolla has arrived and is ready to impress. This compact car is now available for drivers who desire a perfect blend of sophistication and practicality. Unveiling the Corolla's Features The 2025 Toyota Corolla combines sleek design with innovative...
Continue Reading
Royal Unibrew's Annual Report Review for 2024 In a detailed announcement regarding Royal Unibrew's Annual Report for the year 2024, the company has presented a comprehensive view of its operations, performance metrics, and strategic direction. The report is not just a formality; it provides stakeholders significant insights into how the company navigated the challenges of...
Continue Reading
Mullen Group Ltd. Declares Exciting Monthly Dividend Growth The Board of Directors at Mullen Group Ltd. recently made a notable announcement regarding their commitment to returning value to shareholders. This Canadian transport and logistics leader has declared a monthly dividend of $0.07 per Common Share. This decision showcases the corporation's robust financial...
Continue Reading
Avacta Unveils Encouraging Data for AVA6000 Trials Avacta Therapeutics is making strides in the field of oncology with its innovative approach to cancer treatment through peptide drug conjugates (PDC). The company has reported promising early efficacy and safety data from its lead program, AVA6000, which employs the cutting-edge pre|CISION® technology. AVA6000, a...
Continue Reading
SOS Inventory Unveils Comprehensive Rebrand SOS Inventory, recognized as a leading companion for QuickBooks in inventory management, has recently undergone a dynamic rebranding that reflects its ongoing commitment to providing exceptional inventory solutions to businesses everywhere. The transformation includes a newly designed website that enhances user experience and...
Continue Reading